-
Immune checkpoint inhibitors in POLE/POLD1 proofreading-deficient CRC: from molecular basis to clinical practice and future direction
Author: Jiang, Lei; Yang, Zhongxia; Liu, Xiaojun
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2662823
-
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysi
Author: Zhang, Zixuan; Meng, Kehui; Wu, Meiyu; Li, Andong; Yi, Yangke; Shi, Chaohao; Wan, Xiaomin; Tan, Chongqing; Jiang, Zhongbiao
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2660567
-
Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantatio
Author: Wang, Yu; Wu, Jiaying; Huang, Xiaobing; Xiao, Yi
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2644106
-
Cost-effectiveness of first-line immune checkpoint inhibitor therapies, alone or combined with targeted agents, for unresectable hepatocellular carcinoma in China: an economic evaluation using network meta-analysi
Author: Li, Wei; Wan, Li; He, Sijie
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2647585
-
Combination of anti-PD-1 treatment with chemotherapy in a patient with metaplastic breast cancer during lactatio
Author: Song, Jiaqing; Yu, Qinghong; Wu, Hongting; Jin, Ying; Gao, Xiufei
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2623783
-
A case of immune-related adverse events, thyroid dysfunction, myocarditis with myositis, and myasthenia gravis overlap syndrome following serplulimab administration for lung adenocarcinom
Author: Li, Xiaoliang; Feng, Qi; Yu, Yuan; Zhao, Xudong; Wang, Pengxi; Tang, Dafu; Yu, Hailiang
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2619654
-
Multi-omics insights into gut microbial dysbiosis and metabolic alterations in immune checkpoint inhibitor-induced thrombocytopeni
Author: Xu, Bei; Liu, Peng; Yan, Na; Wang, Tao; Liu, Ling; Cheng, Yunfeng
Journal: IMMUNOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2026.2618937
-
A case report of mesalazine alleviating diarrhea in a patient with nasopharyngeal cancer after tislelizumab treatmen
Author: Zhou, Xiaomei; Shu, Yu; Chen, Xi; Luo, Bo
Journal: IMMUNOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1750743X.2025.2504323
